Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
JR McCarthy, IY Sazonova, SS Erdem, T Hara… - …, 2012 - Future Medicine
Background: Current thrombolytic therapies utilize exogenous plasminogen activators (PAs)
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
Multifunctional Nanoagent for Thrombus-Targeted Fibrinolytic Therapy
JR McCarthy, IY Sazonova, SS Erdem, T Hara… - …, 2012 - Taylor & Francis
Background: Current thrombolytic therapies utilize exogenous plasminogen activators (PAs)
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
JR McCarthy, IY Sazonova, SS Erdem, T Hara… - …, 2012 - search.proquest.com
Current thrombolytic therapies utilize exogenous plasminogen activators (PAs) to effectively
lyse clots, restoring blood flow, and preventing tissue and organ death. These PAs may also …
lyse clots, restoring blood flow, and preventing tissue and organ death. These PAs may also …
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
JR McCarthy, IY Sazonova, SS Erdem… - …, 2012 - augusta.elsevierpure.com
Background: Current thrombolytic therapies utilize exogenous plasminogen activators (PAs)
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
[PDF][PDF] Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
JR McCarthy, IY Sazonova, SS Erdem, T Hara… - Nanomedicine …, 2012 - academia.edu
Aims—Current thrombolytic therapies rely upon exogenous plasminogen activators (PA) to
effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death …
effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death …
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy.
JR McCarthy, IY Sazonova, SS Erdem… - Nanomedicine …, 2012 - europepmc.org
Background Current thrombolytic therapies utilize exogenous plasminogen activators (PAs)
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
[PDF][PDF] Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
JR McCarthy, IY Sazonova, SS Erdem… - Nanomedicine …, 2012 - researchgate.net
Aims—Current thrombolytic therapies rely upon exogenous plasminogen activators (PA) to
effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death …
effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death …
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
JR McCarthy, IY Sazonova… - Nanomedicine …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Current thrombolytic therapies utilize exogenous plasminogen activators (PAs)
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
JR McCarthy, IY Sazonova, SS Erdem… - Nanomedicine …, 2012 - dash.harvard.edu
Background: Current thrombolytic therapies utilize exogenous plasminogen activators (PAs)
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
to effectively lyse clots, restoring blood flow, and preventing tissue and organ death. These …
[HTML][HTML] Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
JR McCarthy, IY Sazonova, SS Erdem… - Nanomedicine …, 2012 - ncbi.nlm.nih.gov
Aims Current thrombolytic therapies rely upon exogenous plasminogen activators (PA) to
effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death …
effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death …